Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2025-12-24 @ 9:16 PM
NCT ID:
NCT02022904
Eligibility Criteria:
Inclusion Criteria:
* histologically confirmed diagnosis of adenocarcinoma of the prostate
* Clinical or radiographic evidence of metastatic disease
* Evidence of disease progression on androgen deprivation therapy (ADT) as evidenced by either of the following in the past:
1. Two consecutive PSA levels greater than the PSA nadir achieved on ADT, separated by greater than one week
2. Radiographic evidence of disease progression as defined by new bone scan lesions or soft tissue/visceral metastases \>2 cm in diameter.
3. Clinical progression as determined by the treating physician.
* Age greater than 18 years.
* Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
* History of intercurrent or past medical or psychiatric illness that would make participation in a blood drawing protocol difficult or not feasible at the discretion of the principal investigator or co-investigator(s)
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02022904
Study Brief:
Protocol Section:
NCT02022904